Knights of Columbus Asset Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.85M | Sell |
|
|||||
|
2024
Q3 | $2.56M | Sell |
|
|||||
|
2024
Q2 | $6.48M | Buy |
|
|||||
|
2024
Q1 | $6.42M | Buy |
|
|||||
|
2023
Q4 | $6.09M | Sell |
|
|||||
|
2023
Q3 | $5.37M | Buy |
|
|||||
|
2023
Q2 | $2.86M | Buy |
|
|||||
|
2023
Q1 | $2.04M | Buy |
|
|||||
|
2022
Q4 | $379K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.67M | Buy |
|
|||||
|
2020
Q4 | $1.59M | Sell |
|
|||||
|
2020
Q3 | $2.6M | Buy |
|
|||||
|
2020
Q2 | $2.72M | Buy |
|